Warfarin Sodium
Product Images NDC 70934-589

2 FDA label images from Denton Pharma, Inc. Dba Northwind Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Warfarin Sodium (NDC 70934-589). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Denton Pharma, Inc. Dba Northwind Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Label (70934 589 90 Master Bottle Label Approval Rev A 04 20)

Label (70934 589 90 Master Bottle Label Approval Rev A 04 20)
Warfarin Sodium Tablets USP 5 mg, 90 tablets package label from Denton Pharma, Inc. dba Northwind Pharmaceuticals. The label displays dosage strength, quantity, NDC number 70934-589-90, storage instructions, warnings about serious bleeding risks, and directions to see the package insert for dosage. It includes lot and expiration date placeholders, manufacturing information, and a warning to keep out of reach of children.*
FDA Label Image

Chemical Structure (Warfarin 1)

Chemical Structure (Warfarin 1)
Chemical structure diagram of Warfarin Sodium, showing the molecular configuration including two benzene rings, an oxygen atom, carboxyl group, and sodium atom as part of the compound.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.